Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.41 - $0.91 $22,565 - $50,085
-55,039 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$0.79 - $1.59 $14,714 - $29,615
18,626 Added 51.15%
55,039 $46,000
Q4 2021

Feb 10, 2022

BUY
$1.36 - $2.94 $11,429 - $24,707
8,404 Added 30.0%
36,413 $50,000
Q3 2021

Nov 10, 2021

SELL
$2.97 - $4.84 $1.13 Million - $1.84 Million
-379,414 Reduced 93.13%
28,009 $84,000
Q2 2021

Aug 10, 2021

SELL
$3.71 - $5.13 $714,865 - $988,479
-192,686 Reduced 32.11%
407,423 $1.88 Million
Q1 2021

May 10, 2021

BUY
$4.08 - $14.75 $2.33 Million - $8.41 Million
570,042 Added 1895.91%
600,109 $2.58 Million
Q4 2020

Feb 10, 2021

SELL
$11.06 - $14.01 $221,343 - $280,382
-20,013 Reduced 39.96%
30,067 $333,000
Q3 2020

Nov 13, 2020

BUY
$10.26 - $14.55 $307,430 - $435,976
29,964 Added 148.96%
50,080 $606,000
Q2 2020

Aug 07, 2020

BUY
$7.11 - $13.76 $143,024 - $276,796
20,116 New
20,116 $277,000
Q1 2020

May 15, 2020

SELL
$5.71 - $15.85 $343,804 - $954,344
-60,211 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$9.6 - $17.75 $781,161 - $1.44 Million
-81,371 Reduced 57.47%
60,211 $919,000
Q3 2019

Nov 14, 2019

BUY
$12.16 - $21.0 $1.28 Million - $2.22 Million
105,542 Added 292.85%
141,582 $1.72 Million
Q2 2019

Aug 09, 2019

SELL
$9.44 - $19.8 $67,411 - $141,391
-7,141 Reduced 16.54%
36,040 $714,000
Q1 2019

May 15, 2019

BUY
$11.11 - $13.49 $479,740 - $582,511
43,181 New
43,181 $529,000

Others Institutions Holding ATNX

About Athenex, Inc.


  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.